| Patent | Date |
|---|
Vegf Antagonist Formulations Suitable For Intravitreal Administration
App 20210340220 - FURFINE; Eric ; et al. | 2021-11-04 |
VEGF antagonist formulations suitable for intravitreal administration
Grant 11,084,865 - Furfine , et al. August 10, 2 | 2021-08-10 |
VEGF antagonist formulations suitable for intravitreal administration
Grant 11,066,458 - Furfine , et al. July 20, 2 | 2021-07-20 |
Serum albumin binding molecules
Grant 10,934,572 - Gosselin , et al. March 2, 2 | 2021-03-02 |
Multivalent Fibronectin Based Scaffold Domain Proteins
App 20210017252 - CAMPHAUSEN; Ray ; et al. | 2021-01-21 |
Method of treating cancer by administering multivalent fibronectin based scaffold domain proteins
Grant 10,774,130 - Camphausen , et al. Sept | 2020-09-15 |
Vegf Antagonist Formulations Suitable For Intravitreal Administration
App 20200131246 - FURFINE; Eric ; et al. | 2020-04-30 |
Vegf Antagonist Formulations Suitable For Intravitreal Administration
App 20200017572 - FURFINE; Eric ; et al. | 2020-01-16 |
VEGF antagonist formulations suitable for intravitreal administration
Grant 10,464,992 - Furfine , et al. No | 2019-11-05 |
VEGF antagonist formulations suitable for intravitreal administration
Grant 10,400,025 - Furfine , et al. Sep | 2019-09-03 |
Serum Albumin Binding Molecules
App 20190203248 - GOSSELIN; Michael L. ; et al. | 2019-07-04 |
Serum albumin binding molecules
Grant 10,221,438 - Gosselin , et al. | 2019-03-05 |
Vegf Antagonist Formulations Suitable For Intravitreal Administration
App 20190031735 - FURFINE; Eric ; et al. | 2019-01-31 |
Multivalent Fibronectin Based Scaffold Domain Proteins
App 20180265572 - CAMPHAUSEN; Ray ; et al. | 2018-09-20 |
Vegf Antagonist Formulations Suitable For Intravitreal Administration
App 20180155408 - FURFINE; Eric ; et al. | 2018-06-07 |
VEGF antagonist formulations suitable for intravitreal administration
Grant 9,914,763 - Furfine , et al. March 13, 2 | 2018-03-13 |
Multivalent fibronectin based scaffold domain proteins
Grant 9,902,762 - Camphausen , et al. February 27, 2 | 2018-02-27 |
Serum Albumin Binding Molecules
App 20170145464 - GOSSELIN; Michael L. ; et al. | 2017-05-25 |
VEGF antagonist formulations suitable for intravitreal administration
Grant 9,580,489 - Furfine , et al. February 28, 2 | 2017-02-28 |
Serum albumin binding molecules
Grant 9,540,424 - Gosselin , et al. January 10, 2 | 2017-01-10 |
Vegf Antagonist Formulations Suitable For Intravitreal Administration
App 20160244505 - FURFINE; Eric ; et al. | 2016-08-25 |
Vegf Antagonist Formulations Suitable For Intravitreal Administration
App 20160213608 - FURFINE; Eric ; et al. | 2016-07-28 |
VEGF antagonist formulations for intravitreal administration
Grant 9,340,594 - Furfine , et al. May 17, 2 | 2016-05-17 |
Serum Albumin Binding Molecules
App 20150152147 - GOSSELIN; Michael L. ; et al. | 2015-06-04 |
Serum albumin binding molecules
Grant 8,969,289 - Gosselin , et al. March 3, 2 | 2015-03-03 |
Multivalent Fibronectin Based Scaffold Domain Proteins
App 20140349929 - CAMPHAUSEN; Ray ; et al. | 2014-11-27 |
VEGF Antagonist Formulations for Intravitreal Administration
App 20140323983 - FURFINE; Eric ; et al. | 2014-10-30 |
VEGF antagonist formulations for intravitreal administration
Grant 8,802,107 - Furfine , et al. August 12, 2 | 2014-08-12 |
Multivalent fibronectin based scaffold domain proteins
Grant 8,728,483 - Camphausen , et al. May 20, 2 | 2014-05-20 |
VEGF Antagonist Formulations for Intravitreal Administration
App 20130274189 - FURFINE; Eric ; et al. | 2013-10-17 |
Antitumor Combinations Containing A Vegf-inhibiting Agent And 5fu Or A Derivative Thereof
App 20130184205 - Vrignaud; Patricia ; et al. | 2013-07-18 |
VEGF antagonist formulations for intravitreal administration
Grant 8,481,046 - Furfine , et al. July 9, 2 | 2013-07-09 |
Antitumor combinations containing a VEGF-inhibiting agent and 5FU or a derivative thereof
Grant 8,388,963 - Vrignaud , et al. March 5, 2 | 2013-03-05 |
Multivalent Fibronectin Based Scaffold Domain Proteins
App 20130012435 - Camphausen; Ray ; et al. | 2013-01-10 |
Multivalent fibronectin based scaffold domain proteins
Grant 8,221,765 - Camphausen , et al. July 17, 2 | 2012-07-17 |
VEGF Antagonist Formulations for Intravitreal Administration
App 20120087929 - FURFINE; Eric ; et al. | 2012-04-12 |
VEGF antagonist formulations for intravitreal administration
Grant 8,092,803 - Furfine , et al. January 10, 2 | 2012-01-10 |
Serum Albumin Binding Molecules
App 20110305663 - Gosselin; Michael L. ; et al. | 2011-12-15 |
Vegf Antagonist Formulations For Intravitreal Administration
App 20110257601 - FURFINE; Eric ; et al. | 2011-10-20 |
Lyophilized VEGF antagonist formulations for intravitreal administration
Grant 7,807,164 - Furfine , et al. October 5, 2 | 2010-10-05 |
Vegf Pathway Blockade
App 20100144599 - Mendlein; John ; et al. | 2010-06-10 |
Lyophilized VEGF Antagonist Formulations for Intravitreal Administration
App 20100075903 - FURFINE; Eric ; et al. | 2010-03-25 |
Multivalent Fibronectin Based Scaffold Domain Proteins
App 20090299040 - CAMPHAUSEN; RAY ; et al. | 2009-12-03 |
Antitumor Combinations Containing A Vegf-inhibiting Agent And 5fu Or A Derivative Thereof
App 20090285841 - VRIGNAUD; Patricia ; et al. | 2009-11-19 |
VEGF antagonist formulations suitable for intravitreal administration
Grant 7,608,261 - Furfine , et al. October 27, 2 | 2009-10-27 |
Methods of treating diseases with a VEGF antagonist
Grant 7,531,172 - Stahl , et al. May 12, 2 | 2009-05-12 |
VEGF antagonist formulations suitable for intravitreal administration
App 20070293432 - Furfine; Eric ; et al. | 2007-12-20 |
Methods of treating diseases with a VEGF antagonist
App 20070037748 - Stahl; Neil ; et al. | 2007-02-15 |
Antitumor combinations containing a VEGF-inhibiting agent and 5FU or a derivative thereof
App 20060178305 - Vrignaud; Patricia ; et al. | 2006-08-10 |
| 